Dasari Bobby V, Mergental Hynek, Isaac John R, Muiesan Paolo, Mirza Darius F, Perera Thamara
The Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.
Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13139. Epub 2017 Nov 16.
Due to the current organ shortage, nearly 20% of patients die waiting for a liver transplant (LT). The average donor age is on the rise, and grafts from elderly donors are offered as extended criteria grafts.
This is a meta-analysis comparing the outcome differences of adult patients undergoing LT using grafts from <70-year-old donors vs >70-year-old donors. The primary end-points were graft and patient survival. Secondary outcomes were biliary and vascular complications as well as graft function. The odds ratio (OR) is a summary statistic with the corresponding 95% confidence interval; P < .05 was considered to be statistically significant.
Eight nonrandomized comparative studies with 4376 LT recipients were included. About 79.9% and 20.1% of the grafts were from <70-year-old and >70-year-old donors, respectively. Graft survival at 1 year was similar between the two groups (P = .11), but there was better 3-year and 5-year graft survival in the >70-year-old group (P = .006 and P < .0001, respectively). Patient survival was also similar between the groups at 1 year (P = .54), but with better survival at 3-year and 5-year follow-ups (P = .007 and P < .0001, respectively) in the >70-year-old group. There were no statistically significant differences in the incidence of biliary, vascular, and graft functional-related complications.
Liver grafts from selected >70-year-old donors do not pose added organ-specific risks and thus have comparable transplantation outcomes.
由于目前器官短缺,近20%的患者在等待肝移植(LT)过程中死亡。供体的平均年龄在上升,来自老年供体的移植物被作为扩大标准移植物提供。
这是一项荟萃分析,比较使用年龄<70岁供体的移植物与年龄>70岁供体的移植物进行肝移植的成年患者的结局差异。主要终点是移植物和患者的生存率。次要结局是胆道和血管并发症以及移植物功能。优势比(OR)是一个汇总统计量,对应95%置信区间;P <.05被认为具有统计学意义。
纳入八项非随机对照研究,共4376例肝移植受者。分别约79.9%和20.1%的移植物来自年龄<70岁和>70岁的供体。两组1年时的移植物生存率相似(P =.11),但>70岁组3年和5年的移植物生存率更高(分别为P =.006和P <.0001)。两组1年时的患者生存率也相似(P =.54),但>70岁组在3年和5年随访时生存率更高(分别为P =.007和P <.0001)。胆道、血管和移植物功能相关并发症的发生率无统计学显著差异。
选择的年龄>70岁供体的肝脏移植物不会带来额外的器官特异性风险,因此具有相当的移植结局。